Automatic Point-of-Care System Measures COVID-19 Antibodies Along with HbA1c, CRP, U-Albumin within 3 Minutes

By LabMedica International staff writers
Posted on 06 Oct 2020

Image: Epithod AutoDx analyzer and Epithod SARS-CoV-2 qAb antibody test kit (Photo courtesy of DxGen Corp.)

Image: Epithod AutoDx analyzer and Epithod SARS-CoV-2 qAb antibody test kit (Photo courtesy of DxGen Corp.)

A new automatic point-of-care system measures COVID-19 antibodies along with HbA1c, glycated albumin, hemoglobin, C-reactive protein and U-Albumin within just three minutes.

DxGen Corp. (Korea) has launched the Epithod AutoDx analyzer and Epithod SARS-CoV-2 qAb antibody test kit, which allows to easily test IgM/IgG antibodies to SARS-CoV-2. The Epithod SARS-CoV-2 qAb is a vitro diagnostic (IVD) test that can detect IgM and IgG antibodies produced after virus infection in human whole blood and serum/plasma. According to DxGen, the Epithod SARS-CoV-2 qAb test kit has a sensitivity and specificity of 97% and 100%, respectively at 95% confidence intervals.

The test kit is a gold nanoparticle-based immunoassay for semi-quantitative determination with the easy-to-use Epithod AutoDx analyzer. Users can put the test kit and specimen on the tray and press a button, after which the analyzer perform the entire test process automatically. A key benefit of the Epithod AutoDx analyzer is that in addition to measuring IgM/IgG antibodies to SARS-CoV-2, it can also measure various underlying diseases test markers such as HbA1c, glycated albumin, hemoglobin, C-reactive protein, U-Albumin, etc. By providing medical professionals with various and valuable diagnostic information, the Epithod system can be effectively used not only for COVID-19 diagnosis tests, but also for complication diagnosis tests and patient prognosis monitoring and treatment in various medical front lines.

"We are currently processing the FDA EUA, and we have plan to quickly add test kits such as D-dimer, COVID-19 Antigen, Influenza A/B, etc.," said Dr. Jinwoo Lee, CEO of DxGen Corp.

Visit expo >

Gold Member

Universal Transport Solution

Puritan®UniTranz-RT

3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler

New

DNA/RNA Extraction/Purification Kit

Nucleic Acid Extraction or Purification Kit

New

Silver Member

Quality Control Material

Multichem ID-B

DIASOURCE (A Biovendor Company)

Latest COVID-19 News

Channels

Clinical Chemistry

view channel

Image: Skin swabs could detect Parkinson’s disease up to seven years before symptoms appear (Photo courtesy of The University of Manchester)

Skin Swabs Could Detect Parkinson’s Years Before Symptoms Appear

Parkinson’s disease is notoriously difficult to diagnose in its early stages, as motor symptoms do not appear until later in the progression of the disease. The ability to detect the disease up to seven... Read more

New Clinical Chemistry Analyzer Designed to Meet Growing Demands of Modern Labs

A new clinical chemistry analyzer is designed to provide outstanding performance and maximum efficiency, without compromising affordability, to meet the growing demands of modern laboratories.... Read more

Image: The new research involved using digital PCR as a reference method to standardize test results between laboratories (Photo courtesy of Adobe Stock)

New Reference Measurement Procedure Standardizes Nucleic Acid Amplification Test Results

Nucleic acid amplification tests (NAATs) play a key role in diagnosing a wide range of infectious diseases. These tests are generally known for their high sensitivity and specificity, and they can be developed... Read more

Image: A pen-like tool collects molecules from the skin that can be screened for opioids (Photo courtesy of William Clarke/Johns Hopkins)

Pen-Like Tool Quickly and Non-Invasively Detects Opioids from Skin

Opioid drugs such as fentanyl, morphine, and oxycodone are the primary substances associated with overdose cases in the United States. Standard drug screening procedures typically involve collecting blood,... Read more

Molecular Diagnostics

view channel

Image: The discovery of early markers for ovarian cancer that would have improved sensitivity could aid detection (Photo courtesy of Adobe Stock)

Highly Accurate Biomarkers Could Detect Ovarian Cancer Before Clinical Diagnosis

Ovarian cancer is a deadly and challenging disease, primarily because early detection is difficult. Most women (70-75%) are diagnosed only after the cancer has already spread, which significantly reduces... Read more

New Gene Tool to Enable Earlier Detection and Treatment of Cardiometabolic Diseases

Cardiometabolic diseases, which affect the heart, blood vessels, and the body's ability to process food and generate energy, are difficult to diagnose early due to the complex genetic changes that contribute... Read more

Image: Pathway-specific polygenic scores can predict individual responses to lithium treatment for bipolar disorder (Photo courtesy of Shutterstock)

Genetic Tool Predicts Lithium Responsiveness in Bipolar Disorder Patients

Bipolar disorder (BD) is characterized by cycles of extreme low and high moods. Lithium has long been the gold standard in treating BD since its mood-stabilizing properties were discovered in 1949.... Read more

Image: Proteins in the blood can reveal the severity of malaria (Photo courtesy of Adobe Stock)

Testing Blood Samples for Proteins Can Reveal Malaria Severity

Malaria is a life-threatening disease that can rapidly deteriorate a patient's condition, making it difficult to predict which individuals are at risk of severe outcomes. It remains a challenge to diagnose... Read more

Hematology

view channel

Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Image: The FINDER multifunctional testing platform can run multiple types of tests and deliver rapid results for near-patient use (Photo courtesy of Baebies)

First Point-of-Care Heparin Monitoring Test Provides Results in Under 15 Minutes

Heparin dosing requires careful management to avoid both bleeding and clotting complications. In high-risk situations like extracorporeal membrane oxygenation (ECMO), mortality rates can reach about 50%,... Read more

Image: The 3-parameter CCRS model was devised specifically for patients diagnosed with clonal cytopenia (Photo courtesy of 123RF)

New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder

Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read more

Image: The technology has the unique ability to detect challenging RhD variants that are typically excluded by other commercial tests (Photo courtesy of BillionToOne)

Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy

In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read more

Immunology

view channel

Image: CellLENS enables the potential precision therapy strategies against specific immune cell populations in the tissue environment (Photo courtesy of MIT)

New AI System Uncovers Hidden Cell Subtypes to Advance Cancer Immunotherapy

To produce effective targeted therapies for cancer, scientists need to isolate the genetic and phenotypic characteristics of cancer cells, both within and across different tumors. These differences significantly... Read more

Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Image: The Volition Nu.Q nucleosome assay runs on the IDS i10 automated analyzer platform (Photo courtesy of VolitionRx)

Groundbreaking Lateral Flow Test Quantifies Nucleosomes in Whole Venous Blood in Minutes

Diagnosing immune disruptions quickly and accurately is crucial in conditions such as sepsis, where timely intervention is critical for patient survival. Traditional testing methods can be slow, expensive,... Read more

Image: How the predictive test works (Photo courtesy of QMUL)

World’s First Clinical Test Predicts Best Rheumatoid Arthritis Treatment

Rheumatoid arthritis (RA) is a chronic condition affecting 1 in 100 people in the UK today, causing the immune system to attack its joints. Unlike osteoarthritis, which is caused by wear and tear, RA can... Read more

Microbiology

view channel

Image: Researchers have identified a metabolite produced by gut bacteria as a driver of atherosclerosis (Photo courtesy of CNIC)

Early Detection of Gut Microbiota Metabolite Linked to Atherosclerosis Could Revolutionize Diagnosis

Cardiovascular disease is the leading cause of death worldwide, and atherosclerosis plays a critical role in its development. This chronic condition, characterized by the hardening and narrowing of arteries... Read more

Image: Using viral load tests can help predict mpox severity when skin lesions first appear (Photo courtesy of Laiman Kana Ariga/Nagoya University)

Viral Load Tests Can Help Predict Mpox Severity

Mpox is a viral infection that causes flu-like symptoms and a characteristic rash, which evolves significantly over time and varies between patients. The disease spreads mainly through direct contact with... Read more

Image: Gut microbiota dysbiosis has been linked to the onset and progression of gestational diabetes (Photo courtesy of 123RF)

Gut Microbiota Analysis Enables Early and Non-Invasive Detection of Gestational Diabetes

Gestational diabetes mellitus is a common metabolic disorder marked by abnormal glucose metabolism during pregnancy, typically emerging in the mid to late stages. It significantly heightens the risk of... Read more

Image: The new handheld TB testing device significantly improves disease detection in HIV patients (Photo courtesy of Vincent Postle/Tulane University)

Credit Card-Sized Test Boosts TB Detection in HIV Hotspots

Current tuberculosis (TB) tests face major limitations when it comes to accurately diagnosing the infection in individuals living with HIV. HIV, a frequent co-infection with TB, complicates detection by... Read more

Pathology

view channel

image: BiGraph links local cell patterns to patient survival outcomes, offering interpretable insights into cancer prognosis (Wang, Z. et al., Patterns (2025); doi.org/10.1016/j.patter.2025.101178)

AI Tool Accurately Determines Breast Cancer Prognosis

A new study has found that cells and tissues surrounding a breast cancer tumor may hold critical information about how patients will respond to treatment. The research, published in the journal Patterns,... Read more

image: The new tool called OmicsTweezer uses advanced machine learning techniques to analyze large-scale biological data (Yang, et al., Cell Genomics, 2025; doi.org/10.1016/j.xgen.2025.100950)

Powerful New Tool Improves Tissue Cancer Analysis

Studying the mix of cell types in human tissue is crucial for understanding diseases like cancer, but it presents significant challenges in both accuracy and scalability. The tumor microenvironment, composed... Read more

Image: The machine learning model can predict the aggressiveness of certain types of tumors based on specific proteins (Photo courtesy of Tathiane Malta/USP)

AI-Based Tool Measures Cancer Aggressiveness

As cancer cases continue to rise globally, early diagnosis and precise treatment have become increasingly challenging. Tumors, which are a leading cause of death, are becoming more complex, making it harder... Read more

Image: Micrograph showing the distribution of misfolded proteins in myeloma cells (Photo courtesy of Helmholtz Munich)

Novel Method Tracks Cancer Treatment in Cells Without Dyes or Labels

Multiple myeloma is a blood cancer that affects plasma cells in the bone marrow, leading to abnormal protein production, weakened immunity, and organ damage. Traditional methods for evaluating myeloma... Read more

Technology

view channel

Electronic Biosensors Used to Detect Pathogens Can Rapidly Detect Cancer Cells

A major challenge in healthcare is the early and affordable detection of serious diseases such as cancer. Early diagnosis remains difficult due to the complexity of identifying specific genetic markers... Read more

Image: Student researcher Liyan Ming, first author of the study, setting up a fluorescence imaging experiment (Photo courtesy of Riccardo Marin)

Safer, Portable and Low-Cost Imaging Solution to Revolutionize Biomedical Diagnostics

In diagnosing diseases and monitoring treatment, accurate and quick detection of temperature within biological tissues can be crucial, especially in early disease detection. Conventional methods such as... Read more

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more

Image: Illustration of the high-sensitivity detection of trace amounts of cancer DNA in blood and its analysis using an AI-based method (Photo courtesy of KIMS)

Ultra-Sensitive Biosensor Based on Light and AI Enables Early Cancer Diagnosis

Cancer diagnosis is often delayed due to the difficulty in detecting early-stage cancer markers. In particular, the concentration of methylated DNA in the bloodstream during the early stages of cancer... Read more

Industry

view channel

Image: The fCAL turbo and fPELA turbo assays will be available on the VITROS Systems as an MPA (Photo courtesy of QuidelOrtho)

QuidelOrtho and BÜHLMANN Collaborate on Gastrointestinal Biomarker Tests

QuidelOrtho Corporation (San Diego, CA, USA) and BÜHLMANN Laboratories AG (Schönenbuch, Switzerland) have announced the availability of the BÜHLMANN fCAL turbo and fPELA turbo assays on QuidelOrtho's... Read more

Image: The combined company will have best-in-class liquid chromatography, mass spectrometry, flow cytometry, and diagnostic solutions

BD Biosciences & Diagnostic Solutions to Merge with Waters

BD (Becton, Dickinson and Company, Franklin Lakes, NJ, USA) and Waters Corporation (Milford, MA, USA) have entered into a definitive agreement to combine BD's Biosciences & Diagnostic Solutions... Read more

Image: Whether as a webinar or forum at the trade fair, the accompanying program at COMPAMED is always in high demand (Photo courtesy of Constanze Tillmann)

2025 COMPAMED Innovation Forum Highlights Pioneering Work in Cancer Diagnostics

Cancer cases are among the biggest challenges faced by global healthcare systems. The incidence has risen in recent decades, not least on account of demographic change and escalating risk factors.... Read more

Image: The acquisition will add Akoya’s cutting-edge spatial biology capabilities to Quanterix’s portfolio (Courtesy of Akoya Biosciences)

Quanterix Completes Acquisition of Akoya Biosciences

Quanterix Corporation (Billerica, MA, USA) has completed its previously announced acquisition of Akoya Biosciences (Marlborough, MA, USA), paving the way for the creation of the first integrated solution... Read more